ControversiesChallengesConsensus
}

CX 2019: Experts discuss latest findings from the STEP study

2019-11-01T10:14:03+00:00

Roger Greenhalgh (London, UK) is joined by Fiona Rohlffs (Hamburg, Germany), Tilo Kölbel (Hamburg, Germany) and Heinz Jakob (Essen, Germany) to discuss the latest findings of the Stroke from Thoracic Endovascular Procedures (STEP) study which were presented at CX 2019 (Charing Cross Symposium; 15–18 April 2019, London, UK). […]

CX 2019: Experts discuss latest findings from the STEP study2019-11-01T10:14:03+00:00

MDR will be “the most devastating thing to happen to European healthcare since WW2”

2019-09-16T10:41:45+01:00

Speaking at the Charing Cross Symposium 2019, Jeffrey Jump (Nyon, Switzerland), outlines the impact of the Medical Device Regulations (MDR), which he believes will be “the most devastating thing to happen to European healthcare in Europe since World War Two”.

Patients “will bear the brunt of this hardship” says Jump, who […]

MDR will be “the most devastating thing to happen to European healthcare since WW2”2019-09-16T10:41:45+01:00

With CoveredSeal, Valiant Navion™ offers physicians the “best of both worlds” for TEVAR procedures

2019-09-06T16:05:44+01:00

Paul Hayes (Cambridge, UK), Frank Arko (Charlotte, USA) and Fabio Verzini (Turin, Italy) discuss the Valiant Navion™ (Medtronic) live thoracic endovascular aortic repair (TEVAR) case at Charing Cross 2019, which demonstrated the use of the new CoveredSeal proximal configuration.

Hayes talks about the accuracy of the device’s deployment around the thoracic […]

With CoveredSeal, Valiant Navion™ offers physicians the “best of both worlds” for TEVAR procedures2019-09-06T16:05:44+01:00

Durability of endovascular aneurysm repair and the NICE guidelines

2019-09-06T16:08:53+01:00

A CX 2019 special session highlighted the durability of endovascular aneurysm repair (EVAR) and the implications of the UK National Institute for Health and Care Excellence (NICE) draft aortic aneurysm guidelines. The final publication of these guidelines has been postponed on numerous occasions.

Opening the session, Stéphan Haulon and his team […]

Durability of endovascular aneurysm repair and the NICE guidelines2019-09-06T16:08:53+01:00

VenaSeal maintains safety and efficacy at extended five-year follow-up

2019-04-16T21:52:45+01:00

Nick Morrison

The first-ever 60-month data on Medtronic’s VenaSeal closure system were presented on Tuesday, indicating that at five years, treatment with the cyanoacrylate adhesive for closure of diseased vein segments was not inferior to the alternative treatment arm of radiofrequency ablation (RFA). Nick Morrison of […]

VenaSeal maintains safety and efficacy at extended five-year follow-up2019-04-16T21:52:45+01:00

CX Special Session will discuss the use of paclitaxel devices

2019-09-06T16:37:19+01:00

CX Executive Board Members Gunnar Tepe and Thomas Zeller introduce the CX Special Session which aims to give the last word on paclitaxel and work with the vascular community to find the way forward.

Watch the video below, and see the final CX 2019 programme here.

[…]

CX Special Session will discuss the use of paclitaxel devices2019-09-06T16:37:19+01:00

CX 2019 Vascular Access Programme Highlights

2019-09-06T16:38:16+01:00

Nicholas Inston, member of the CX Vascular Access Executive Board, gives the highlights for this year’s CX Vascular Access Masterclass which will focus on the maintenance and not just the formation of vascular access.

CX 2019 Vascular Access Programme Highlights2019-09-06T16:38:16+01:00
Go to Top